Trial Profile
Effect of midazolam on pharmacokinetics of alectinib in cancer patients.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Alectinib (Primary) ; Midazolam
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- 22 Apr 2016 New trial record
- 12 Mar 2016 Results from this trial and other two trial (CTP 237396, 238878) presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics